X-ray manufacturer Del Global Technologies posted what it calls the strongest fourth-quarter and fiscal-year results in its history. These 1998 figures are the result of a combination of internal revenue growth and a strong outsourcing trend by global
X-ray manufacturer Del Global Technologies posted what it calls the strongest fourth-quarter and fiscal-year results in its history. These 1998 figures are the result of a combination of internal revenue growth and a strong outsourcing trend by global medical equipment manufacturers.
For the year (end-August), Del reported net sales of $62.3 million, a 14% increase from the $54.7 million the company posted in 1997. Net income was $5.8 million, compared with the previous years $4.9 million.
Dels fourth-quarter revenues were also strong at $17.7 million, up 15% from $15.4 million in the fourth quarter of 1997. Net income for the period was $1.7 million, compared with $1.5 million the year before.
Medical imaging sales now contribute 80% of the Valhalla, NY, companys revenues, according to chief executive Leonard Trugman. The companys backlog stood at $36 million at year end.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.